JACQUELYN RENNEBERG: Open Payments
NPI 1275048118 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 58 payments from 16 companies in 2025. Trend: 2023 $3,246 · 2024 $4,452 · 2025 $1,215
Food & beverage: $1,215
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $189 |
| Medtronic, Inc. | 2 | $173 |
| Novartis Pharmaceuticals Corporation | 9 | $169 |
| Abbott Laboratories | 11 | $150 |
| Actelion Pharmaceuticals US, Inc. | 4 | $131 |
| BridgeBio Pharma, Inc. | 3 | $106 |
| Boston Scientific Corporation | 4 | $89 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
Products named: LINQ II, LEQVIO, ELIQUIS, Attruby, OPSUMIT, BodyGuardian, CARDIOMEMS, VERQUVO.
Industry payments across TX — which companies pay providers there.
